Outbreak of multi-resistant Klebsiella oxytoca involving strains with extended-spectrum β-lactamases and strains with extended-spectrum activity of the chromosomal β-lactamase

被引:53
|
作者
Decré, D
Burghoffer, B
Gautier, V
Petit, JC
Arlet, G
机构
[1] Univ Paris 06, UPRES No EA2392, Fac Med, UFR St Antoine, F-75012 Paris 12, France
[2] Hop St Antoine, Bacteriol Lab, F-75012 Paris 12, France
[3] Assisatnce Publ Hop Paris, Bacteriol Lab, Hop Tenon, Paris, France
关键词
OXY-2; beta-lactamase; TEM-7; TEM-129;
D O I
10.1093/jac/dkh440
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: This study was conducted to analyse broad-spectrum cephalosporin-resistant Klebsiella oxytoca strains. Methods: The 57 isolates studied were recovered from clinical specimens (n=23) or from rectal swabs (n=34) during a 26-month period. Antibiotic susceptibility patterns were determined using standard agar diffusion and dilution methods including the synergy test between extended-spectrum cephalosporins and clavulanic acid. ERIC-2 PCR and pulsed-field gel electrophoresis (PFGE) methods were used to study the clonal relatedness of the strains. Plasmid-mediated and chromosomal beta-lactamases were characterized by mating and specific bla gene amplification and sequencing. Results: Four different antibiotic resistance patterns were identified whereas ERIC-2 PCR and PFGE revealed six main profiles. Extended-spectrum beta-lactamases (ESBLs) were found in 32 strains: TEM-7 (n=26), TEM-129 (n=1), TEM-3 (n=4), SHV-2 (n=1). The new TEM-type beta-lactamase, TEM-129, differed from TEM-7 by one mutation (Glu-104-->Lys). All TEM-7 or TEM-129 producers were genetically related. Twenty-five other strains with identical ERIC-2 PCR and PFGE profiles harboured a bla(OXY-2) gene different from the reference gene: 24 strains displayed one substitution (Ala-237-->Ser) in the KTG motif and one strain, highly resistant to ceftazidime, showed an additional substitution (Pro-167-->Ser). Conclusions: The study demonstrated that the majority of strains (n=52) harbouring the OXY-2-type beta-lactamase corresponded to two clones. The first clone (n=27) corresponded to ESBL-producing strains. The second clone (n=25) displayed extended-spectrum activity of the chromosomal beta-lactamase.
引用
收藏
页码:881 / 888
页数:8
相关论文
共 50 条
  • [31] Extended-spectrum β-lactamase (ESBL) producing Enterobacteriaceae and extended-spectrum cephalosporins in 2012
    Lefort, A.
    Nicolas-Chanoine, M. -H.
    JOURNAL DES ANTI-INFECTIEUX, 2012, 14 (02) : 51 - 57
  • [32] Russian Klebsiella pneumoniae isolates that express extended-spectrum β-lactamases
    Winokur, PL
    Eidelstain, MV
    Stetsiouk, O
    Stratchounski, L
    Blahova, J
    Reshedko, GK
    Croco, MAT
    Hollis, RJ
    Pfaller, MA
    Jones, RN
    CLINICAL MICROBIOLOGY AND INFECTION, 2000, 6 (02) : 103 - 108
  • [33] Detection of antimicrobial resistance and extended-spectrum β-lactamase production in Klebsiella pneumoniae strains from infected neonates
    Aktas, E
    Yigit, N
    Yazgi, H
    Ayyildiz, A
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2002, 30 (04) : 445 - 448
  • [34] Relationship between ciprofloxacin resistance and extended-spectrum β-lactamase production in Escherichia coli and Klebsiella pneumoniae strains
    Tolun, V
    Küçükbasmaci, Ö
    Törümküney-Akbulut, D
    Çatal, Ç
    Ang-Küçüker, M
    Ang, Ö
    CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (01) : 72 - 75
  • [35] Characterization of Klebsiella pneumoniae clinical strains producing a rare extended-spectrum β-lactamase (IBC-1)
    Vourli, S
    Tzouvelekis, LS
    Tzelepi, E
    Kartali, G
    Kontopoulou, C
    Sofianou, D
    Tzouvelekis, LS
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2003, 21 (05) : 495 - 497
  • [36] Genetic support of extended-spectrum β-lactamases
    Poirel, L.
    Naas, T.
    Nordmann, P.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 75 - 81
  • [37] Extended-spectrum β-lactamases:: a clinical update
    Paterson, DL
    Bonomo, RA
    CLINICAL MICROBIOLOGY REVIEWS, 2005, 18 (04) : 657 - +
  • [38] Extended-spectrum beta-lactamases
    Philippon, A.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2013, 28 (5-6): : 287 - 296
  • [39] Clinical significance of extended-spectrum β-lactamases
    Rodriguez-Bano, Jesus
    Pascual, Alvaro
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (05) : 671 - 683
  • [40] Extended-spectrum β-lactamases and the permeability barrier
    Martinez-Martinez, L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2008, 14 : 82 - 89